Write in a clean editor, then format for Amyloid in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Amyloid is a peer-reviewed journal published by Taylor & Francis, covering Amyloidosis: Diagnosis, Treatment, Outcomes, Alzheimer's disease research and treatments, Parathyroid Disorders and Treatments.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Amyloid 12 (3): 45–58.
Formats any DOI in Amyloid style. No sign-up. |
| Publishes research in | Amyloidosis: Diagnosis, Treatment, Outcomes Alzheimer's disease research and treatments Parathyroid Disorders and Treatments Dermatological and Skeletal Disorders Protein Kinase Regulation and GTPase Signaling |
| ISSN | 1350-6129 |
| Citation impact (2-yr) | 3.35 |
| h-index | 89 |
| i10-index | 889 |
| Total citations | 41,487 |
| Top institutions publishing here | Shinshu University |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The Nomenclature Committee of the International Society of Amyloidosis (ISA) met during the XVth Symposium of the Society, 3 July-7 July 2016, Uppsala, Sweden, to assess and formulate recommendations for nomenclature for amyloid fibril proteins and the clinical classification of the amyloidoses. An amyloid fibril must exhibit affinity for Congo red and with green, yellow…
The nomenclature committee of the International Society of Amyloidosis (ISA) meets every second year to discuss and formulate recommendations. The conclusions from the discussion at the XVI International Symposium on Amyloidosis in Kumamoto, Japan, 25-29 March 2018 and afterwards are summarized in this Nomenclature Article. From having recommended the use of the designation "amyloid fibril"…
The Nomenclature Committee of the International Society of Amyloidosis (ISA) met during the XIVth Symposium of the Society, April 27–May 1, 2014, Indianapolis, IN, to assess and formulate recommend...
Thioflavin T (ThT) has been widely used to investigate amyloid formation since 1989. While concerns have recently been raised about its use as a probe specific for amyloid, ThT still continues to be a very valuable tool for studying kinetic aspects of fibrillation and associated inhibition mechanisms. This review aims to provide a conceptual instruction…
